Getinge (GETI B.ST) Aandeel Koers
Getinge Koers
De omzet is de afgelopen 19 jaar met 5,3% per jaar gegroeid tot 34,97 Miljard SEK. De winst per aandeel is de afgelopen 19 jaar met 3,1% per jaar gegroeid. De nettowinstmarge van Getinge ligt op 6,5% en is ten opzichte van 11,0% enkele jaren eerder gedaald. Getinge biedt momenteel een dividendrendement van circa 1,67%. De uitkeringsratio ligt rond 55% van de winst. Het dividend is de afgelopen 19 jaar met 4,7% per jaar gegroeid. Analisten hanteren een mediaan koersdoel van 231,03 SEK — dat impliceert 16,2% onder de huidige koers. Van de 14 analisten geven 8 het aandeel een koopadvies — per saldo een Kopen-consensus.
Getinge aandeelkoers
Deze data ophalen via de Eulerpool API
100.000 requests/maand gratis · geen creditcard
Getinge bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over Getinge
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Analisten hanteren momenteel een gemiddeld koersdoel van 238,81 SEK voor het aandeel Getinge (mediaan: 231,03 SEK), oftewel -13,4 % ten opzichte van de laatste koers. De consensus is gebaseerd op 14 analistenratings.
14 analisten beoordelen het aandeel Getinge momenteel: 8 adviseren kopen, 5 houden en 1 verkopen. Voor 2026 verwachten analisten dat Getinge een omzet van 35,26 Miljard SEK en winst per aandeel van 12,89 SEK behaalt.
Omgezet tegen de huidige wisselkoers noteert het aandeel Getinge op 25,03 EUR (275,80 SEK).
Het aandeel Getinge (GETI B.ST) is genoteerd aan 9 beurzen, waaronder: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
De verwachte omzet van Getinge bedraagt 35,26 Miljard SEK. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.
De verwachte winst van Getinge bedraagt 3,51 Miljard SEK. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.
De koers-winstverhouding (P/E) van Getinge bedraagt momenteel 21,40. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het Getinge-aandeel in te schatten.
De koers-omzetverhouding (P/S) van Getinge bedraagt momenteel 2,13. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het Getinge-aandeel.
De Eulerpool Kwaliteitsscore voor Getinge is 4/10.
De ISIN van Getinge is SE0000202624. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
De WKN van Getinge is 889714. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.
Het tickersymbool van Getinge is GETI B.ST. Onder dit beurstickersymbool wordt het Getinge-aandeel op de beurs verhandeld.
Getinge aandeel
Getinge Peer Group
Getinge Ticker
Getinge FIGI
Alle fundamentals en diepgaande analyse van Getinge
Onze aandelenanalyse van het Getinge-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van Getinge. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: